Microbial Biomarkers in Clinical Chemistry, Diagnostic and Prognostic Application: A Review

Authors

  • Hams Ahmed Al-Jndeel Department of Pharmaceutical Chemistry, College of Pharmacy, University of Kerbala, Karbala, Iraq
  • Haneen Saeed Mohsin Department of Pharmaceutical Chemistry, College of Pharmacy, University of Kerbala, Karbala, Iraq
  • Ahmed Abbas Hasan Department of Pharmaceutical Chemistry, College of Pharmacy, University of Kerbala, Karbala, Iraq
  • Heba Akram Mohsin Department of Pharmaceutical Chemistry, College of Pharmacy, University of Kerbala, Karbala, Iraq

DOI:

https://doi.org/10.62472/kjps.v16.i27.318-327

Keywords:

Clinical chemistry, metabolomic, biochemical biomarkers, host-pathogen

Abstract

Background

These biomarkers assisted medical professionals in predicting clinical outcomes, guiding antibiotic stewardship, and differentiating between infectious and non-infectious inflammatory illnesses. However, the limitations of traditional biomarkers such as poor specificity, inter-patient variability, and overlap with non-infectious diseases led to the development of more sophisticated diagnostic instruments. Real-time PCR, multiplex pathogen detection panels, and next-generation sequencing NGS. are examples of significant advancements in molecular diagnostics that have expanded the biomarker spectrum beyond host derived analytes to include direct microbial fingerprints. Even in complex or culture-negative disorders, accurate organism identification was made possible by metagenomic sequencing, microbial cell free DNA, and pathogen-specific proteins. Precision medicine initiatives were encouraged, diagnostic accuracy was enhanced, and early detection was made possible when these molecular approaches were integrated with traditional clinical chemistry processes. Emerging multi-omics tools, such as proteomics, metabolomics, transcriptomics, and microbiome profiling, have enabled the discovery of novel biomarkers that captured dynamic host-pathogen interactions at previously un heard of resolution. In order to maximize patient survival and reduce unnecessary drug exposure, timely and correct diagnosis was essential. Infectious illnesses continued to be a major worldwide health burden. Because it provided an overview of current research on host response, biomarkers and pathogen, directed molecular technologies and demonstrated how their combination improved clinical decision making, antibiotic stewardship, and individualized patient care, The goal of this study. The goal of this study is to provide a thorough evaluation of both traditional biochemical biomarkers and advanced molecular diagnostic methods, highlighting their combined diagnostic and prognostic significance in infectious diseases. This review also aims to highlight current problems, clinical applications, and possible future directions to improve the accuracy of pathogen detection and patient treatment.

Downloads

Published

2025-12-31